Shionogi Partners with Cloudera to Accelerate R&D and Achieve Data-Driven Innovation in Pharmaceuticals

0

Discovery-based pharmaceutical company in Japan leverages Cloudera to gain faster insights into its research, development, and post-market value chain.

SINGAPORE, April 5, 2022 /PRNewswire/ — Clouderathe hybrid data cloud company, today announced that the Japanese pharmaceutical company, Shionogi & Co., Ltd., chose Cloudera to strengthen its data analytics capabilities to increase business performance and realize its vision of data-driven innovation. Through this partnership, Shionogi hopes to democratize access to its vast amounts of data and promote data literacy to accelerate research and product launches.

As a discovery-based pharmaceutical company, Shionogi is focused on researching and developing more effective drugs and pharmaceuticals to protect the health and well-being of patients. The large amounts of data that Shionogi generates and relies on resides in silos on different platforms spread across various locations. To realize its vision of true data-driven innovation, Shionogi needed a comprehensive data platform that could quickly aggregate and analyze that data in a secure and governed way. Democratizing access to this data while maintaining data security and governance was key.

Cloudera worked with Shionogi to upgrade its existing data platform to Cloudera Data Platform (CDP), a secure and organized platform that easily integrates into the various other systems used by Shionogi. The company has integrated all of its data silos, with the CDP functioning as a consolidated database. The single source of truth provides easy access to data, which has increased the productivity of its engineers and data scientists by making it easier to share information across the organization, thereby improving data literacy within Shionogi. CDP seamlessly connects to business intelligence (BI) tools and analytics systems while providing security and governance, enabling Shionogi to accelerate drug discovery and development hypothesis and testing cycles .

Dr. Yoshitake Kitanishi, Vice President of Data Science, Shionogi & Co. Ltd., said, “Shionogi believes we will need to optimize the use of our collective data and knowledge to achieve true data-driven innovation. data. The Cloudera Data Platform is what we need – a secure, organized and integrated database. Its ability to aggregate and analyze a wide variety of internal and external data, structured or unstructured, allows it to quickly process large volumes of data. We can get business insights quickly because it seamlessly connects to BI tools and analytics systems while meeting privacy and other compliance requirements.”

“We are excited to support Shionogi in using data to transform their business. The company is currently working on drugs for COVID-19 and we are proud to be part of this process. Cloudera’s scalable hybrid data cloud will help Shionogi achieve its goal. to be a data-driven company,” said Takeshi OsawaGeneral manager, JapanCloudera.

Additional Resources

About Cloudera
At Cloudera, we believe that data can make possible tomorrow what is impossible today. Cloudera has taught the world the value of Big Data, creating an industry and ecosystem fueled by the relentless innovation of the open source community. We empower our industry-leading clients to turn complex data into clear, actionable insights. With our hybrid data cloud platform, organizations are able to build their data-driven future by putting data – no matter where it resides – into the hands of those who need it. Learn more at Cloudera.com.

Cloudera and related marks are trademarks or registered trademarks of Cloudera, Inc. All other company and product names are trademarks of their respective owners.

SOURCECloudera, Inc.

Share.

Comments are closed.